Coronavirus live news: WHO says Covid won’t be over this year; China aims to vaccinate 40% of population by June

France has eased restrictions on giving the AstraZeneca vaccine to people aged over 65 after new trial data proved the shot was effective, health minister Olivier Véran has said.

While the EMA, the bloc’s drug regulator, approved the AstraZeneca jab for use by all adults, health agencies in many EU countries, including France and Germany, advised against its use for the over-65s pending more trial data from older age groups.

The French president, Emmanuel Macron, sparked consternation by telling journalists it was “quasi-ineffective” for the over-65s, but last week said more data had since become available and he would take the jab if offered.

Véran told French TV that “anybody aged 50 or over who is affected by co-morbidities can get the AstraZeneca vaccine, including those between 65 and 74.” Those over 75 would continue to be given only the Pfizer and Moderna shots only, he said.

The decision means another 1.5m people are eligible from today for AstraZeneca vaccines from family doctors, with France’s slow rollout soon also to be extended to pharmacies. Véran said France should deliver a further 6m first jabs this month.

Meanwhile the French government spokesman, Gabriel Attal, said today all options remained open to rein in rising infection numbers in some areas, including a new national lockdown and regional weekend lockdowns. Le Monde reported that the Paris area could be placed in weekend lockdown from next weekend.

The world has only a few months to prevent the energy industry’s carbon emissions from surpassing pre-pandemic levels this year as economies begin to rebound from Covid-19 restrictions, according to the International Energy Agency.

New figures from the global energy watchdog found that fossil fuel emissions climbed steadily over the second half of the year as major economies began to recover. By December 2020, carbon emissions were 2% higher than in the same month the year before:

Scientists have warned that emerging data on long Covid in children should not be ignored given the lack of a vaccine for this age group, but cautioned that the evidence describing these enduring symptoms in the young is so far uncertain.

Recently published data from the Office for National Statistics (ONS) has caused worry. The data suggest that 13% of under 11s and about 15% of 12- to 16-year-olds reported at least one symptom five weeks after a confirmed Covid-19 infection. ONS samples households randomly, therefore positive cases do not depend on having had symptoms and being tested:

Powered by WPeMatico